Click Here To Download Our Most Recent Sure Analysis Report On Johnson & Johnson.pdf

JNJ-2022-10-18.pdf
Preview of Click here to download our most recent Sure Analysis report on Johnson & Johnson
🔗 Source: suredividend.com
📊 Size: 326 KB
👤 Author: Ben Reynolds
⬇️ Downloads: 220

Summary

Johnson & Johnson (JNJ) is a diversified healthcare company with a market cap of $438 billion, current price of $166, and a 5-year CAGR estimate of 9.0%. The company has a dividend yield of 2.7%, 60 years of dividend growth, and a fair value price of $171. JNJ's revenue is expected to be at least $95 billion this year, with pharmaceuticals, medical devices, and consumer products making up 49%, 34%, and 17% of sales, respectively. The company plans to spin off its consumer health business into a standalone company within 18-24 months. JNJ's third-quarter earnings results showed revenue growth of 2% to $23.8 billion, with adjusted earnings-per-share of $2.55. The company expects adjusted earnings-per-share of $10.02 to $10.07 for the year and has revised its guidance due to a strengthening US dollar. JNJ has grown earnings at a rate of 7.5% over the past 10 years and is expected to grow earnings-per-share at a rate of 6% per year through 2027. The company's valuation analysis shows a price-to-earnings ratio of 16.5, which is below the target price-to-earnings ratio of 17. JNJ has a reasonably low dividend payout ratio, a competitive advantage due to its size and scale, and a diversification that allows it to continue growing even if one segment underperforms. The total return breakdown estimates a 9.0% total annual return through 2027, with a 6% earnings growth rate, a starting yield of 2.7%, and a small contribution from multiple expansion. The recommendation is to hold shares of JNJ due to projected returns.

Description

Johnson & Johnson (JNJ) is a diversified healthcare company with a market cap of $438 billion, current price of $166, and a 5-year CAGR estimate of 9.0%.

Technical Information

  • File Format: PDF
  • File Size: 326 KB
  • Pages: 3
  • Language: EN
  • Author: Ben Reynolds
  • Total Downloads: 220
  • Last Updated: 1 week ago

Document Overview

This PDF document about Click here to download our most recent Sure Analysis report on Johnson & Johnson provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Click here to download our most recent Sure Analysis report on Johnson & Johnson.

Related Topics

If you're interested in Click here to download our most recent Sure Analysis report on Johnson & Johnson, you might also want to explore:

Download Click here to download our most recent Sure Analysis report on Johnson & Johnson eBooks for free and learn more about Click here to download our most recent Sure Analysis report on Johnson & Johnson. These books contain exercises and tutorials to improve your practical skills, at all levels!

Not satisfied with this document? We have related documents to Click here to download our most recent Sure Analysis report on Johnson & Johnson, try searching with similar keywords: Click here to download our most recent Sure Analysis report on Johnson & Johnson, Click here to download our most recent Sure Analysis report on TSM, Click here to download our most recent Sure Analysis report on Office Properties (GWLIF), Click here to download our most recent Sure Analysis report on UnitedHealth, Click here to download our most recent Sure Analysis report on NYMT, Click here to download our most recent Sure Analysis report on National Retail Properties, Click here to download our most recent Sure Analysis report on PSEC, Click here to download our most recent Sure Analysis report on BEP

You can download PDF versions of the user's guide, manuals and ebooks about Click here to download our most recent Sure Analysis report on Johnson & Johnson, you can also find and download for free A free online manual (notices) with beginner and intermediate, Downloads Documentation, You can download PDF files (or DOC and PPT) about Click here to download our most recent Sure Analysis report on Johnson & Johnson for free, but please respect copyrighted ebooks.